Firmenporträt Oncopeptides AB
ISIN SE0009414576
Stammdaten
| Name | Oncopeptides AB | Gründung | 2000 |
| Sitz | Luntmakargatan 46, vån 7 111 37 Stockholm | Geschäftsjahresende | 01.01. |
| Internet | https://www.oncopeptides.se/ | Gezeichnetes Kapital | - |
| Telefon | +4686152040 | Aktiennennwert | - |
| Telefax | Management |  | |
| WKN | A2DLU2 | Aufsichtsrat | |
| Prime Sector | - | ||
| Aktionärsstruktur |
Streubesitz 30,50% HEALTHCAP VI LP 16,72% STIFTELSEN INDUSTRIFONDEN 10,96% Swedbank Robur Funds 5,83% Handelsbanken Funds 4,82% JP MORGAN BANK LUXEMBOURG S.A. 4,73% 4th AP Fund 4,72% GLADIATOR 4,71% STATE STREET BANK AND TRUST CO, W9 3,57% MORGAN STANLEY AND CO LLC, W9 3,42% Avanza Pension 2,06% SEB-Foundation 1,98% AMF ? Insurance and Funds 1,88% Nordic and Europe health Invest AS 1,62% AFA Insurance 1,37% 2nd AP-Fund 1,11% |
||